Global Human Plasma Derivative Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Plasma derivatives are products manufactured from human plasma by chromatographic and other fractionation techniques.
LPI (LP Information)' newest research report, the “Human Plasma Derivative Industry Forecast” looks at past sales and reviews total world Human Plasma Derivative sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Plasma Derivative sales for 2023 through 2029. With Human Plasma Derivative sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Plasma Derivative industry.
This Insight Report provides a comprehensive analysis of the global Human Plasma Derivative landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Plasma Derivative portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Human Plasma Derivative market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Plasma Derivative and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Plasma Derivative.
The global Human Plasma Derivative market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Human Plasma Derivative is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Human Plasma Derivative is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Human Plasma Derivative is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Human Plasma Derivative players cover CSL Behring, Baxalta (Takeda), Grifols, Octapharma, SK Plasma, Fusion Health Care, Baxter International, Beijing Tiantan Biological Products Corporation and Hualan Biological, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Plasma Derivative market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Human Plasma Derivative market?
What factors are driving Human Plasma Derivative market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Plasma Derivative market opportunities vary by end market size?
How does Human Plasma Derivative break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Plasma derivatives are products manufactured from human plasma by chromatographic and other fractionation techniques.
LPI (LP Information)' newest research report, the “Human Plasma Derivative Industry Forecast” looks at past sales and reviews total world Human Plasma Derivative sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Plasma Derivative sales for 2023 through 2029. With Human Plasma Derivative sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Plasma Derivative industry.
This Insight Report provides a comprehensive analysis of the global Human Plasma Derivative landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Plasma Derivative portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Human Plasma Derivative market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Plasma Derivative and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Plasma Derivative.
The global Human Plasma Derivative market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Human Plasma Derivative is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Human Plasma Derivative is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Human Plasma Derivative is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Human Plasma Derivative players cover CSL Behring, Baxalta (Takeda), Grifols, Octapharma, SK Plasma, Fusion Health Care, Baxter International, Beijing Tiantan Biological Products Corporation and Hualan Biological, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Plasma Derivative market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Albumin
- Blood coagulation Factors
- Immuno Globulins
- Haptoglobin
- C1-Inactivator
- Hospitals
- Clinics
- Biology Laboratory
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CSL Behring
- Baxalta (Takeda)
- Grifols
- Octapharma
- SK Plasma
- Fusion Health Care
- Baxter International
- Beijing Tiantan Biological Products Corporation
- Hualan Biological
- Shanghai RAAS Blood Products
- Shandong Taibang Biological Products
- China Resources Boya Bio-pharmaceutical Group
What is the 10-year outlook for the global Human Plasma Derivative market?
What factors are driving Human Plasma Derivative market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Plasma Derivative market opportunities vary by end market size?
How does Human Plasma Derivative break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Plasma Derivative Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Human Plasma Derivative by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Human Plasma Derivative by Country/Region, 2018, 2022 & 2029
2.2 Human Plasma Derivative Segment by Type
2.2.1 Albumin
2.2.2 Blood coagulation Factors
2.2.3 Immuno Globulins
2.2.4 Haptoglobin
2.2.5 C1-Inactivator
2.3 Human Plasma Derivative Sales by Type
2.3.1 Global Human Plasma Derivative Sales Market Share by Type (2018-2023)
2.3.2 Global Human Plasma Derivative Revenue and Market Share by Type (2018-2023)
2.3.3 Global Human Plasma Derivative Sale Price by Type (2018-2023)
2.4 Human Plasma Derivative Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Biology Laboratory
2.4.4 Others
2.5 Human Plasma Derivative Sales by Application
2.5.1 Global Human Plasma Derivative Sale Market Share by Application (2018-2023)
2.5.2 Global Human Plasma Derivative Revenue and Market Share by Application (2018-2023)
2.5.3 Global Human Plasma Derivative Sale Price by Application (2018-2023)
3 GLOBAL HUMAN PLASMA DERIVATIVE BY COMPANY
3.1 Global Human Plasma Derivative Breakdown Data by Company
3.1.1 Global Human Plasma Derivative Annual Sales by Company (2018-2023)
3.1.2 Global Human Plasma Derivative Sales Market Share by Company (2018-2023)
3.2 Global Human Plasma Derivative Annual Revenue by Company (2018-2023)
3.2.1 Global Human Plasma Derivative Revenue by Company (2018-2023)
3.2.2 Global Human Plasma Derivative Revenue Market Share by Company (2018-2023)
3.3 Global Human Plasma Derivative Sale Price by Company
3.4 Key Manufacturers Human Plasma Derivative Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Plasma Derivative Product Location Distribution
3.4.2 Players Human Plasma Derivative Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUMAN PLASMA DERIVATIVE BY GEOGRAPHIC REGION
4.1 World Historic Human Plasma Derivative Market Size by Geographic Region (2018-2023)
4.1.1 Global Human Plasma Derivative Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Human Plasma Derivative Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Human Plasma Derivative Market Size by Country/Region (2018-2023)
4.2.1 Global Human Plasma Derivative Annual Sales by Country/Region (2018-2023)
4.2.2 Global Human Plasma Derivative Annual Revenue by Country/Region (2018-2023)
4.3 Americas Human Plasma Derivative Sales Growth
4.4 APAC Human Plasma Derivative Sales Growth
4.5 Europe Human Plasma Derivative Sales Growth
4.6 Middle East & Africa Human Plasma Derivative Sales Growth
5 AMERICAS
5.1 Americas Human Plasma Derivative Sales by Country
5.1.1 Americas Human Plasma Derivative Sales by Country (2018-2023)
5.1.2 Americas Human Plasma Derivative Revenue by Country (2018-2023)
5.2 Americas Human Plasma Derivative Sales by Type
5.3 Americas Human Plasma Derivative Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Plasma Derivative Sales by Region
6.1.1 APAC Human Plasma Derivative Sales by Region (2018-2023)
6.1.2 APAC Human Plasma Derivative Revenue by Region (2018-2023)
6.2 APAC Human Plasma Derivative Sales by Type
6.3 APAC Human Plasma Derivative Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Plasma Derivative by Country
7.1.1 Europe Human Plasma Derivative Sales by Country (2018-2023)
7.1.2 Europe Human Plasma Derivative Revenue by Country (2018-2023)
7.2 Europe Human Plasma Derivative Sales by Type
7.3 Europe Human Plasma Derivative Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Plasma Derivative by Country
8.1.1 Middle East & Africa Human Plasma Derivative Sales by Country (2018-2023)
8.1.2 Middle East & Africa Human Plasma Derivative Revenue by Country (2018-2023)
8.2 Middle East & Africa Human Plasma Derivative Sales by Type
8.3 Middle East & Africa Human Plasma Derivative Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Plasma Derivative
10.3 Manufacturing Process Analysis of Human Plasma Derivative
10.4 Industry Chain Structure of Human Plasma Derivative
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Plasma Derivative Distributors
11.3 Human Plasma Derivative Customer
12 WORLD FORECAST REVIEW FOR HUMAN PLASMA DERIVATIVE BY GEOGRAPHIC REGION
12.1 Global Human Plasma Derivative Market Size Forecast by Region
12.1.1 Global Human Plasma Derivative Forecast by Region (2024-2029)
12.1.2 Global Human Plasma Derivative Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Plasma Derivative Forecast by Type
12.7 Global Human Plasma Derivative Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Human Plasma Derivative Product Portfolios and Specifications
13.1.3 CSL Behring Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Baxalta (Takeda)
13.2.1 Baxalta (Takeda) Company Information
13.2.2 Baxalta (Takeda) Human Plasma Derivative Product Portfolios and Specifications
13.2.3 Baxalta (Takeda) Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Baxalta (Takeda) Main Business Overview
13.2.5 Baxalta (Takeda) Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Human Plasma Derivative Product Portfolios and Specifications
13.3.3 Grifols Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Human Plasma Derivative Product Portfolios and Specifications
13.4.3 Octapharma Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 SK Plasma
13.5.1 SK Plasma Company Information
13.5.2 SK Plasma Human Plasma Derivative Product Portfolios and Specifications
13.5.3 SK Plasma Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 SK Plasma Main Business Overview
13.5.5 SK Plasma Latest Developments
13.6 Fusion Health Care
13.6.1 Fusion Health Care Company Information
13.6.2 Fusion Health Care Human Plasma Derivative Product Portfolios and Specifications
13.6.3 Fusion Health Care Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Fusion Health Care Main Business Overview
13.6.5 Fusion Health Care Latest Developments
13.7 Baxter International
13.7.1 Baxter International Company Information
13.7.2 Baxter International Human Plasma Derivative Product Portfolios and Specifications
13.7.3 Baxter International Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Baxter International Main Business Overview
13.7.5 Baxter International Latest Developments
13.8 Beijing Tiantan Biological Products Corporation
13.8.1 Beijing Tiantan Biological Products Corporation Company Information
13.8.2 Beijing Tiantan Biological Products Corporation Human Plasma Derivative Product Portfolios and Specifications
13.8.3 Beijing Tiantan Biological Products Corporation Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Beijing Tiantan Biological Products Corporation Main Business Overview
13.8.5 Beijing Tiantan Biological Products Corporation Latest Developments
13.9 Hualan Biological
13.9.1 Hualan Biological Company Information
13.9.2 Hualan Biological Human Plasma Derivative Product Portfolios and Specifications
13.9.3 Hualan Biological Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hualan Biological Main Business Overview
13.9.5 Hualan Biological Latest Developments
13.10 Shanghai RAAS Blood Products
13.10.1 Shanghai RAAS Blood Products Company Information
13.10.2 Shanghai RAAS Blood Products Human Plasma Derivative Product Portfolios and Specifications
13.10.3 Shanghai RAAS Blood Products Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shanghai RAAS Blood Products Main Business Overview
13.10.5 Shanghai RAAS Blood Products Latest Developments
13.11 Shandong Taibang Biological Products
13.11.1 Shandong Taibang Biological Products Company Information
13.11.2 Shandong Taibang Biological Products Human Plasma Derivative Product Portfolios and Specifications
13.11.3 Shandong Taibang Biological Products Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shandong Taibang Biological Products Main Business Overview
13.11.5 Shandong Taibang Biological Products Latest Developments
13.12 China Resources Boya Bio-pharmaceutical Group
13.12.1 China Resources Boya Bio-pharmaceutical Group Company Information
13.12.2 China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Product Portfolios and Specifications
13.12.3 China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 China Resources Boya Bio-pharmaceutical Group Main Business Overview
13.12.5 China Resources Boya Bio-pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Plasma Derivative Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Human Plasma Derivative by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Human Plasma Derivative by Country/Region, 2018, 2022 & 2029
2.2 Human Plasma Derivative Segment by Type
2.2.1 Albumin
2.2.2 Blood coagulation Factors
2.2.3 Immuno Globulins
2.2.4 Haptoglobin
2.2.5 C1-Inactivator
2.3 Human Plasma Derivative Sales by Type
2.3.1 Global Human Plasma Derivative Sales Market Share by Type (2018-2023)
2.3.2 Global Human Plasma Derivative Revenue and Market Share by Type (2018-2023)
2.3.3 Global Human Plasma Derivative Sale Price by Type (2018-2023)
2.4 Human Plasma Derivative Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Biology Laboratory
2.4.4 Others
2.5 Human Plasma Derivative Sales by Application
2.5.1 Global Human Plasma Derivative Sale Market Share by Application (2018-2023)
2.5.2 Global Human Plasma Derivative Revenue and Market Share by Application (2018-2023)
2.5.3 Global Human Plasma Derivative Sale Price by Application (2018-2023)
3 GLOBAL HUMAN PLASMA DERIVATIVE BY COMPANY
3.1 Global Human Plasma Derivative Breakdown Data by Company
3.1.1 Global Human Plasma Derivative Annual Sales by Company (2018-2023)
3.1.2 Global Human Plasma Derivative Sales Market Share by Company (2018-2023)
3.2 Global Human Plasma Derivative Annual Revenue by Company (2018-2023)
3.2.1 Global Human Plasma Derivative Revenue by Company (2018-2023)
3.2.2 Global Human Plasma Derivative Revenue Market Share by Company (2018-2023)
3.3 Global Human Plasma Derivative Sale Price by Company
3.4 Key Manufacturers Human Plasma Derivative Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Plasma Derivative Product Location Distribution
3.4.2 Players Human Plasma Derivative Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUMAN PLASMA DERIVATIVE BY GEOGRAPHIC REGION
4.1 World Historic Human Plasma Derivative Market Size by Geographic Region (2018-2023)
4.1.1 Global Human Plasma Derivative Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Human Plasma Derivative Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Human Plasma Derivative Market Size by Country/Region (2018-2023)
4.2.1 Global Human Plasma Derivative Annual Sales by Country/Region (2018-2023)
4.2.2 Global Human Plasma Derivative Annual Revenue by Country/Region (2018-2023)
4.3 Americas Human Plasma Derivative Sales Growth
4.4 APAC Human Plasma Derivative Sales Growth
4.5 Europe Human Plasma Derivative Sales Growth
4.6 Middle East & Africa Human Plasma Derivative Sales Growth
5 AMERICAS
5.1 Americas Human Plasma Derivative Sales by Country
5.1.1 Americas Human Plasma Derivative Sales by Country (2018-2023)
5.1.2 Americas Human Plasma Derivative Revenue by Country (2018-2023)
5.2 Americas Human Plasma Derivative Sales by Type
5.3 Americas Human Plasma Derivative Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Plasma Derivative Sales by Region
6.1.1 APAC Human Plasma Derivative Sales by Region (2018-2023)
6.1.2 APAC Human Plasma Derivative Revenue by Region (2018-2023)
6.2 APAC Human Plasma Derivative Sales by Type
6.3 APAC Human Plasma Derivative Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Plasma Derivative by Country
7.1.1 Europe Human Plasma Derivative Sales by Country (2018-2023)
7.1.2 Europe Human Plasma Derivative Revenue by Country (2018-2023)
7.2 Europe Human Plasma Derivative Sales by Type
7.3 Europe Human Plasma Derivative Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Plasma Derivative by Country
8.1.1 Middle East & Africa Human Plasma Derivative Sales by Country (2018-2023)
8.1.2 Middle East & Africa Human Plasma Derivative Revenue by Country (2018-2023)
8.2 Middle East & Africa Human Plasma Derivative Sales by Type
8.3 Middle East & Africa Human Plasma Derivative Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Plasma Derivative
10.3 Manufacturing Process Analysis of Human Plasma Derivative
10.4 Industry Chain Structure of Human Plasma Derivative
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Plasma Derivative Distributors
11.3 Human Plasma Derivative Customer
12 WORLD FORECAST REVIEW FOR HUMAN PLASMA DERIVATIVE BY GEOGRAPHIC REGION
12.1 Global Human Plasma Derivative Market Size Forecast by Region
12.1.1 Global Human Plasma Derivative Forecast by Region (2024-2029)
12.1.2 Global Human Plasma Derivative Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Plasma Derivative Forecast by Type
12.7 Global Human Plasma Derivative Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 CSL Behring
13.1.1 CSL Behring Company Information
13.1.2 CSL Behring Human Plasma Derivative Product Portfolios and Specifications
13.1.3 CSL Behring Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 CSL Behring Main Business Overview
13.1.5 CSL Behring Latest Developments
13.2 Baxalta (Takeda)
13.2.1 Baxalta (Takeda) Company Information
13.2.2 Baxalta (Takeda) Human Plasma Derivative Product Portfolios and Specifications
13.2.3 Baxalta (Takeda) Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Baxalta (Takeda) Main Business Overview
13.2.5 Baxalta (Takeda) Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Human Plasma Derivative Product Portfolios and Specifications
13.3.3 Grifols Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Human Plasma Derivative Product Portfolios and Specifications
13.4.3 Octapharma Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 SK Plasma
13.5.1 SK Plasma Company Information
13.5.2 SK Plasma Human Plasma Derivative Product Portfolios and Specifications
13.5.3 SK Plasma Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 SK Plasma Main Business Overview
13.5.5 SK Plasma Latest Developments
13.6 Fusion Health Care
13.6.1 Fusion Health Care Company Information
13.6.2 Fusion Health Care Human Plasma Derivative Product Portfolios and Specifications
13.6.3 Fusion Health Care Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Fusion Health Care Main Business Overview
13.6.5 Fusion Health Care Latest Developments
13.7 Baxter International
13.7.1 Baxter International Company Information
13.7.2 Baxter International Human Plasma Derivative Product Portfolios and Specifications
13.7.3 Baxter International Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Baxter International Main Business Overview
13.7.5 Baxter International Latest Developments
13.8 Beijing Tiantan Biological Products Corporation
13.8.1 Beijing Tiantan Biological Products Corporation Company Information
13.8.2 Beijing Tiantan Biological Products Corporation Human Plasma Derivative Product Portfolios and Specifications
13.8.3 Beijing Tiantan Biological Products Corporation Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Beijing Tiantan Biological Products Corporation Main Business Overview
13.8.5 Beijing Tiantan Biological Products Corporation Latest Developments
13.9 Hualan Biological
13.9.1 Hualan Biological Company Information
13.9.2 Hualan Biological Human Plasma Derivative Product Portfolios and Specifications
13.9.3 Hualan Biological Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hualan Biological Main Business Overview
13.9.5 Hualan Biological Latest Developments
13.10 Shanghai RAAS Blood Products
13.10.1 Shanghai RAAS Blood Products Company Information
13.10.2 Shanghai RAAS Blood Products Human Plasma Derivative Product Portfolios and Specifications
13.10.3 Shanghai RAAS Blood Products Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shanghai RAAS Blood Products Main Business Overview
13.10.5 Shanghai RAAS Blood Products Latest Developments
13.11 Shandong Taibang Biological Products
13.11.1 Shandong Taibang Biological Products Company Information
13.11.2 Shandong Taibang Biological Products Human Plasma Derivative Product Portfolios and Specifications
13.11.3 Shandong Taibang Biological Products Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shandong Taibang Biological Products Main Business Overview
13.11.5 Shandong Taibang Biological Products Latest Developments
13.12 China Resources Boya Bio-pharmaceutical Group
13.12.1 China Resources Boya Bio-pharmaceutical Group Company Information
13.12.2 China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Product Portfolios and Specifications
13.12.3 China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 China Resources Boya Bio-pharmaceutical Group Main Business Overview
13.12.5 China Resources Boya Bio-pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Plasma Derivative Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Human Plasma Derivative Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Albumin
Table 4. Major Players of Blood coagulation Factors
Table 5. Major Players of Immuno Globulins
Table 6. Major Players of Haptoglobin
Table 7. Major Players of C1-Inactivator
Table 8. Global Human Plasma Derivative Sales by Type (2018-2023) & (Tons)
Table 9. Global Human Plasma Derivative Sales Market Share by Type (2018-2023)
Table 10. Global Human Plasma Derivative Revenue by Type (2018-2023) & ($ million)
Table 11. Global Human Plasma Derivative Revenue Market Share by Type (2018-2023)
Table 12. Global Human Plasma Derivative Sale Price by Type (2018-2023) & (US$/Ton)
Table 13. Global Human Plasma Derivative Sales by Application (2018-2023) & (Tons)
Table 14. Global Human Plasma Derivative Sales Market Share by Application (2018-2023)
Table 15. Global Human Plasma Derivative Revenue by Application (2018-2023)
Table 16. Global Human Plasma Derivative Revenue Market Share by Application (2018-2023)
Table 17. Global Human Plasma Derivative Sale Price by Application (2018-2023) & (US$/Ton)
Table 18. Global Human Plasma Derivative Sales by Company (2018-2023) & (Tons)
Table 19. Global Human Plasma Derivative Sales Market Share by Company (2018-2023)
Table 20. Global Human Plasma Derivative Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Human Plasma Derivative Revenue Market Share by Company (2018-2023)
Table 22. Global Human Plasma Derivative Sale Price by Company (2018-2023) & (US$/Ton)
Table 23. Key Manufacturers Human Plasma Derivative Producing Area Distribution and Sales Area
Table 24. Players Human Plasma Derivative Products Offered
Table 25. Human Plasma Derivative Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Human Plasma Derivative Sales by Geographic Region (2018-2023) & (Tons)
Table 29. Global Human Plasma Derivative Sales Market Share Geographic Region (2018-2023)
Table 30. Global Human Plasma Derivative Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Human Plasma Derivative Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Human Plasma Derivative Sales by Country/Region (2018-2023) & (Tons)
Table 33. Global Human Plasma Derivative Sales Market Share by Country/Region (2018-2023)
Table 34. Global Human Plasma Derivative Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Human Plasma Derivative Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Human Plasma Derivative Sales by Country (2018-2023) & (Tons)
Table 37. Americas Human Plasma Derivative Sales Market Share by Country (2018-2023)
Table 38. Americas Human Plasma Derivative Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Human Plasma Derivative Revenue Market Share by Country (2018-2023)
Table 40. Americas Human Plasma Derivative Sales by Type (2018-2023) & (Tons)
Table 41. Americas Human Plasma Derivative Sales by Application (2018-2023) & (Tons)
Table 42. APAC Human Plasma Derivative Sales by Region (2018-2023) & (Tons)
Table 43. APAC Human Plasma Derivative Sales Market Share by Region (2018-2023)
Table 44. APAC Human Plasma Derivative Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Human Plasma Derivative Revenue Market Share by Region (2018-2023)
Table 46. APAC Human Plasma Derivative Sales by Type (2018-2023) & (Tons)
Table 47. APAC Human Plasma Derivative Sales by Application (2018-2023) & (Tons)
Table 48. Europe Human Plasma Derivative Sales by Country (2018-2023) & (Tons)
Table 49. Europe Human Plasma Derivative Sales Market Share by Country (2018-2023)
Table 50. Europe Human Plasma Derivative Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Human Plasma Derivative Revenue Market Share by Country (2018-2023)
Table 52. Europe Human Plasma Derivative Sales by Type (2018-2023) & (Tons)
Table 53. Europe Human Plasma Derivative Sales by Application (2018-2023) & (Tons)
Table 54. Middle East & Africa Human Plasma Derivative Sales by Country (2018-2023) & (Tons)
Table 55. Middle East & Africa Human Plasma Derivative Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Human Plasma Derivative Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Human Plasma Derivative Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Human Plasma Derivative Sales by Type (2018-2023) & (Tons)
Table 59. Middle East & Africa Human Plasma Derivative Sales by Application (2018-2023) & (Tons)
Table 60. Key Market Drivers & Growth Opportunities of Human Plasma Derivative
Table 61. Key Market Challenges & Risks of Human Plasma Derivative
Table 62. Key Industry Trends of Human Plasma Derivative
Table 63. Human Plasma Derivative Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Human Plasma Derivative Distributors List
Table 66. Human Plasma Derivative Customer List
Table 67. Global Human Plasma Derivative Sales Forecast by Region (2024-2029) & (Tons)
Table 68. Global Human Plasma Derivative Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Human Plasma Derivative Sales Forecast by Country (2024-2029) & (Tons)
Table 70. Americas Human Plasma Derivative Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Human Plasma Derivative Sales Forecast by Region (2024-2029) & (Tons)
Table 72. APAC Human Plasma Derivative Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Human Plasma Derivative Sales Forecast by Country (2024-2029) & (Tons)
Table 74. Europe Human Plasma Derivative Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Human Plasma Derivative Sales Forecast by Country (2024-2029) & (Tons)
Table 76. Middle East & Africa Human Plasma Derivative Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Human Plasma Derivative Sales Forecast by Type (2024-2029) & (Tons)
Table 78. Global Human Plasma Derivative Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Human Plasma Derivative Sales Forecast by Application (2024-2029) & (Tons)
Table 80. Global Human Plasma Derivative Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. CSL Behring Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 82. CSL Behring Human Plasma Derivative Product Portfolios and Specifications
Table 83. CSL Behring Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 84. CSL Behring Main Business
Table 85. CSL Behring Latest Developments
Table 86. Baxalta (Takeda) Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 87. Baxalta (Takeda) Human Plasma Derivative Product Portfolios and Specifications
Table 88. Baxalta (Takeda) Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 89. Baxalta (Takeda) Main Business
Table 90. Baxalta (Takeda) Latest Developments
Table 91. Grifols Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 92. Grifols Human Plasma Derivative Product Portfolios and Specifications
Table 93. Grifols Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 94. Grifols Main Business
Table 95. Grifols Latest Developments
Table 96. Octapharma Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 97. Octapharma Human Plasma Derivative Product Portfolios and Specifications
Table 98. Octapharma Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 99. Octapharma Main Business
Table 100. Octapharma Latest Developments
Table 101. SK Plasma Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 102. SK Plasma Human Plasma Derivative Product Portfolios and Specifications
Table 103. SK Plasma Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 104. SK Plasma Main Business
Table 105. SK Plasma Latest Developments
Table 106. Fusion Health Care Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 107. Fusion Health Care Human Plasma Derivative Product Portfolios and Specifications
Table 108. Fusion Health Care Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 109. Fusion Health Care Main Business
Table 110. Fusion Health Care Latest Developments
Table 111. Baxter International Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 112. Baxter International Human Plasma Derivative Product Portfolios and Specifications
Table 113. Baxter International Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 114. Baxter International Main Business
Table 115. Baxter International Latest Developments
Table 116. Beijing Tiantan Biological Products Corporation Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 117. Beijing Tiantan Biological Products Corporation Human Plasma Derivative Product Portfolios and Specifications
Table 118. Beijing Tiantan Biological Products Corporation Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 119. Beijing Tiantan Biological Products Corporation Main Business
Table 120. Beijing Tiantan Biological Products Corporation Latest Developments
Table 121. Hualan Biological Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 122. Hualan Biological Human Plasma Derivative Product Portfolios and Specifications
Table 123. Hualan Biological Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 124. Hualan Biological Main Business
Table 125. Hualan Biological Latest Developments
Table 126. Shanghai RAAS Blood Products Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 127. Shanghai RAAS Blood Products Human Plasma Derivative Product Portfolios and Specifications
Table 128. Shanghai RAAS Blood Products Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 129. Shanghai RAAS Blood Products Main Business
Table 130. Shanghai RAAS Blood Products Latest Developments
Table 131. Shandong Taibang Biological Products Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 132. Shandong Taibang Biological Products Human Plasma Derivative Product Portfolios and Specifications
Table 133. Shandong Taibang Biological Products Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 134. Shandong Taibang Biological Products Main Business
Table 135. Shandong Taibang Biological Products Latest Developments
Table 136. China Resources Boya Bio-pharmaceutical Group Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 137. China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Product Portfolios and Specifications
Table 138. China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 139. China Resources Boya Bio-pharmaceutical Group Main Business
Table 140. China Resources Boya Bio-pharmaceutical Group Latest Developments
Table 1. Human Plasma Derivative Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Human Plasma Derivative Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Albumin
Table 4. Major Players of Blood coagulation Factors
Table 5. Major Players of Immuno Globulins
Table 6. Major Players of Haptoglobin
Table 7. Major Players of C1-Inactivator
Table 8. Global Human Plasma Derivative Sales by Type (2018-2023) & (Tons)
Table 9. Global Human Plasma Derivative Sales Market Share by Type (2018-2023)
Table 10. Global Human Plasma Derivative Revenue by Type (2018-2023) & ($ million)
Table 11. Global Human Plasma Derivative Revenue Market Share by Type (2018-2023)
Table 12. Global Human Plasma Derivative Sale Price by Type (2018-2023) & (US$/Ton)
Table 13. Global Human Plasma Derivative Sales by Application (2018-2023) & (Tons)
Table 14. Global Human Plasma Derivative Sales Market Share by Application (2018-2023)
Table 15. Global Human Plasma Derivative Revenue by Application (2018-2023)
Table 16. Global Human Plasma Derivative Revenue Market Share by Application (2018-2023)
Table 17. Global Human Plasma Derivative Sale Price by Application (2018-2023) & (US$/Ton)
Table 18. Global Human Plasma Derivative Sales by Company (2018-2023) & (Tons)
Table 19. Global Human Plasma Derivative Sales Market Share by Company (2018-2023)
Table 20. Global Human Plasma Derivative Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Human Plasma Derivative Revenue Market Share by Company (2018-2023)
Table 22. Global Human Plasma Derivative Sale Price by Company (2018-2023) & (US$/Ton)
Table 23. Key Manufacturers Human Plasma Derivative Producing Area Distribution and Sales Area
Table 24. Players Human Plasma Derivative Products Offered
Table 25. Human Plasma Derivative Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Human Plasma Derivative Sales by Geographic Region (2018-2023) & (Tons)
Table 29. Global Human Plasma Derivative Sales Market Share Geographic Region (2018-2023)
Table 30. Global Human Plasma Derivative Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Human Plasma Derivative Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Human Plasma Derivative Sales by Country/Region (2018-2023) & (Tons)
Table 33. Global Human Plasma Derivative Sales Market Share by Country/Region (2018-2023)
Table 34. Global Human Plasma Derivative Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Human Plasma Derivative Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Human Plasma Derivative Sales by Country (2018-2023) & (Tons)
Table 37. Americas Human Plasma Derivative Sales Market Share by Country (2018-2023)
Table 38. Americas Human Plasma Derivative Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Human Plasma Derivative Revenue Market Share by Country (2018-2023)
Table 40. Americas Human Plasma Derivative Sales by Type (2018-2023) & (Tons)
Table 41. Americas Human Plasma Derivative Sales by Application (2018-2023) & (Tons)
Table 42. APAC Human Plasma Derivative Sales by Region (2018-2023) & (Tons)
Table 43. APAC Human Plasma Derivative Sales Market Share by Region (2018-2023)
Table 44. APAC Human Plasma Derivative Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Human Plasma Derivative Revenue Market Share by Region (2018-2023)
Table 46. APAC Human Plasma Derivative Sales by Type (2018-2023) & (Tons)
Table 47. APAC Human Plasma Derivative Sales by Application (2018-2023) & (Tons)
Table 48. Europe Human Plasma Derivative Sales by Country (2018-2023) & (Tons)
Table 49. Europe Human Plasma Derivative Sales Market Share by Country (2018-2023)
Table 50. Europe Human Plasma Derivative Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Human Plasma Derivative Revenue Market Share by Country (2018-2023)
Table 52. Europe Human Plasma Derivative Sales by Type (2018-2023) & (Tons)
Table 53. Europe Human Plasma Derivative Sales by Application (2018-2023) & (Tons)
Table 54. Middle East & Africa Human Plasma Derivative Sales by Country (2018-2023) & (Tons)
Table 55. Middle East & Africa Human Plasma Derivative Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Human Plasma Derivative Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Human Plasma Derivative Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Human Plasma Derivative Sales by Type (2018-2023) & (Tons)
Table 59. Middle East & Africa Human Plasma Derivative Sales by Application (2018-2023) & (Tons)
Table 60. Key Market Drivers & Growth Opportunities of Human Plasma Derivative
Table 61. Key Market Challenges & Risks of Human Plasma Derivative
Table 62. Key Industry Trends of Human Plasma Derivative
Table 63. Human Plasma Derivative Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Human Plasma Derivative Distributors List
Table 66. Human Plasma Derivative Customer List
Table 67. Global Human Plasma Derivative Sales Forecast by Region (2024-2029) & (Tons)
Table 68. Global Human Plasma Derivative Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Human Plasma Derivative Sales Forecast by Country (2024-2029) & (Tons)
Table 70. Americas Human Plasma Derivative Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Human Plasma Derivative Sales Forecast by Region (2024-2029) & (Tons)
Table 72. APAC Human Plasma Derivative Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Human Plasma Derivative Sales Forecast by Country (2024-2029) & (Tons)
Table 74. Europe Human Plasma Derivative Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Human Plasma Derivative Sales Forecast by Country (2024-2029) & (Tons)
Table 76. Middle East & Africa Human Plasma Derivative Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Human Plasma Derivative Sales Forecast by Type (2024-2029) & (Tons)
Table 78. Global Human Plasma Derivative Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Human Plasma Derivative Sales Forecast by Application (2024-2029) & (Tons)
Table 80. Global Human Plasma Derivative Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. CSL Behring Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 82. CSL Behring Human Plasma Derivative Product Portfolios and Specifications
Table 83. CSL Behring Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 84. CSL Behring Main Business
Table 85. CSL Behring Latest Developments
Table 86. Baxalta (Takeda) Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 87. Baxalta (Takeda) Human Plasma Derivative Product Portfolios and Specifications
Table 88. Baxalta (Takeda) Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 89. Baxalta (Takeda) Main Business
Table 90. Baxalta (Takeda) Latest Developments
Table 91. Grifols Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 92. Grifols Human Plasma Derivative Product Portfolios and Specifications
Table 93. Grifols Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 94. Grifols Main Business
Table 95. Grifols Latest Developments
Table 96. Octapharma Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 97. Octapharma Human Plasma Derivative Product Portfolios and Specifications
Table 98. Octapharma Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 99. Octapharma Main Business
Table 100. Octapharma Latest Developments
Table 101. SK Plasma Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 102. SK Plasma Human Plasma Derivative Product Portfolios and Specifications
Table 103. SK Plasma Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 104. SK Plasma Main Business
Table 105. SK Plasma Latest Developments
Table 106. Fusion Health Care Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 107. Fusion Health Care Human Plasma Derivative Product Portfolios and Specifications
Table 108. Fusion Health Care Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 109. Fusion Health Care Main Business
Table 110. Fusion Health Care Latest Developments
Table 111. Baxter International Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 112. Baxter International Human Plasma Derivative Product Portfolios and Specifications
Table 113. Baxter International Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 114. Baxter International Main Business
Table 115. Baxter International Latest Developments
Table 116. Beijing Tiantan Biological Products Corporation Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 117. Beijing Tiantan Biological Products Corporation Human Plasma Derivative Product Portfolios and Specifications
Table 118. Beijing Tiantan Biological Products Corporation Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 119. Beijing Tiantan Biological Products Corporation Main Business
Table 120. Beijing Tiantan Biological Products Corporation Latest Developments
Table 121. Hualan Biological Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 122. Hualan Biological Human Plasma Derivative Product Portfolios and Specifications
Table 123. Hualan Biological Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 124. Hualan Biological Main Business
Table 125. Hualan Biological Latest Developments
Table 126. Shanghai RAAS Blood Products Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 127. Shanghai RAAS Blood Products Human Plasma Derivative Product Portfolios and Specifications
Table 128. Shanghai RAAS Blood Products Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 129. Shanghai RAAS Blood Products Main Business
Table 130. Shanghai RAAS Blood Products Latest Developments
Table 131. Shandong Taibang Biological Products Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 132. Shandong Taibang Biological Products Human Plasma Derivative Product Portfolios and Specifications
Table 133. Shandong Taibang Biological Products Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 134. Shandong Taibang Biological Products Main Business
Table 135. Shandong Taibang Biological Products Latest Developments
Table 136. China Resources Boya Bio-pharmaceutical Group Basic Information, Human Plasma Derivative Manufacturing Base, Sales Area and Its Competitors
Table 137. China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Product Portfolios and Specifications
Table 138. China Resources Boya Bio-pharmaceutical Group Human Plasma Derivative Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 139. China Resources Boya Bio-pharmaceutical Group Main Business
Table 140. China Resources Boya Bio-pharmaceutical Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Plasma Derivative
Figure 2. Human Plasma Derivative Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Plasma Derivative Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Human Plasma Derivative Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Human Plasma Derivative Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Albumin
Figure 10. Product Picture of Blood coagulation Factors
Figure 11. Product Picture of Immuno Globulins
Figure 12. Product Picture of Haptoglobin
Figure 13. Product Picture of C1-Inactivator
Figure 14. Global Human Plasma Derivative Sales Market Share by Type in 2022
Figure 15. Global Human Plasma Derivative Revenue Market Share by Type (2018-2023)
Figure 16. Human Plasma Derivative Consumed in Hospitals
Figure 17. Global Human Plasma Derivative Market: Hospitals (2018-2023) & (Tons)
Figure 18. Human Plasma Derivative Consumed in Clinics
Figure 19. Global Human Plasma Derivative Market: Clinics (2018-2023) & (Tons)
Figure 20. Human Plasma Derivative Consumed in Biology Laboratory
Figure 21. Global Human Plasma Derivative Market: Biology Laboratory (2018-2023) & (Tons)
Figure 22. Human Plasma Derivative Consumed in Others
Figure 23. Global Human Plasma Derivative Market: Others (2018-2023) & (Tons)
Figure 24. Global Human Plasma Derivative Sales Market Share by Application (2022)
Figure 25. Global Human Plasma Derivative Revenue Market Share by Application in 2022
Figure 26. Human Plasma Derivative Sales Market by Company in 2022 (Tons)
Figure 27. Global Human Plasma Derivative Sales Market Share by Company in 2022
Figure 28. Human Plasma Derivative Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Human Plasma Derivative Revenue Market Share by Company in 2022
Figure 30. Global Human Plasma Derivative Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Human Plasma Derivative Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Human Plasma Derivative Sales 2018-2023 (Tons)
Figure 33. Americas Human Plasma Derivative Revenue 2018-2023 ($ Millions)
Figure 34. APAC Human Plasma Derivative Sales 2018-2023 (Tons)
Figure 35. APAC Human Plasma Derivative Revenue 2018-2023 ($ Millions)
Figure 36. Europe Human Plasma Derivative Sales 2018-2023 (Tons)
Figure 37. Europe Human Plasma Derivative Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Human Plasma Derivative Sales 2018-2023 (Tons)
Figure 39. Middle East & Africa Human Plasma Derivative Revenue 2018-2023 ($ Millions)
Figure 40. Americas Human Plasma Derivative Sales Market Share by Country in 2022
Figure 41. Americas Human Plasma Derivative Revenue Market Share by Country in 2022
Figure 42. Americas Human Plasma Derivative Sales Market Share by Type (2018-2023)
Figure 43. Americas Human Plasma Derivative Sales Market Share by Application (2018-2023)
Figure 44. United States Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Human Plasma Derivative Sales Market Share by Region in 2022
Figure 49. APAC Human Plasma Derivative Revenue Market Share by Regions in 2022
Figure 50. APAC Human Plasma Derivative Sales Market Share by Type (2018-2023)
Figure 51. APAC Human Plasma Derivative Sales Market Share by Application (2018-2023)
Figure 52. China Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Human Plasma Derivative Sales Market Share by Country in 2022
Figure 60. Europe Human Plasma Derivative Revenue Market Share by Country in 2022
Figure 61. Europe Human Plasma Derivative Sales Market Share by Type (2018-2023)
Figure 62. Europe Human Plasma Derivative Sales Market Share by Application (2018-2023)
Figure 63. Germany Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Human Plasma Derivative Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Human Plasma Derivative Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Human Plasma Derivative Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Human Plasma Derivative Sales Market Share by Application (2018-2023)
Figure 72. Egypt Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Human Plasma Derivative in 2022
Figure 78. Manufacturing Process Analysis of Human Plasma Derivative
Figure 79. Industry Chain Structure of Human Plasma Derivative
Figure 80. Channels of Distribution
Figure 81. Global Human Plasma Derivative Sales Market Forecast by Region (2024-2029)
Figure 82. Global Human Plasma Derivative Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Human Plasma Derivative Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Human Plasma Derivative Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Human Plasma Derivative Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Human Plasma Derivative Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Human Plasma Derivative
Figure 2. Human Plasma Derivative Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Plasma Derivative Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Human Plasma Derivative Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Human Plasma Derivative Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Albumin
Figure 10. Product Picture of Blood coagulation Factors
Figure 11. Product Picture of Immuno Globulins
Figure 12. Product Picture of Haptoglobin
Figure 13. Product Picture of C1-Inactivator
Figure 14. Global Human Plasma Derivative Sales Market Share by Type in 2022
Figure 15. Global Human Plasma Derivative Revenue Market Share by Type (2018-2023)
Figure 16. Human Plasma Derivative Consumed in Hospitals
Figure 17. Global Human Plasma Derivative Market: Hospitals (2018-2023) & (Tons)
Figure 18. Human Plasma Derivative Consumed in Clinics
Figure 19. Global Human Plasma Derivative Market: Clinics (2018-2023) & (Tons)
Figure 20. Human Plasma Derivative Consumed in Biology Laboratory
Figure 21. Global Human Plasma Derivative Market: Biology Laboratory (2018-2023) & (Tons)
Figure 22. Human Plasma Derivative Consumed in Others
Figure 23. Global Human Plasma Derivative Market: Others (2018-2023) & (Tons)
Figure 24. Global Human Plasma Derivative Sales Market Share by Application (2022)
Figure 25. Global Human Plasma Derivative Revenue Market Share by Application in 2022
Figure 26. Human Plasma Derivative Sales Market by Company in 2022 (Tons)
Figure 27. Global Human Plasma Derivative Sales Market Share by Company in 2022
Figure 28. Human Plasma Derivative Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Human Plasma Derivative Revenue Market Share by Company in 2022
Figure 30. Global Human Plasma Derivative Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Human Plasma Derivative Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Human Plasma Derivative Sales 2018-2023 (Tons)
Figure 33. Americas Human Plasma Derivative Revenue 2018-2023 ($ Millions)
Figure 34. APAC Human Plasma Derivative Sales 2018-2023 (Tons)
Figure 35. APAC Human Plasma Derivative Revenue 2018-2023 ($ Millions)
Figure 36. Europe Human Plasma Derivative Sales 2018-2023 (Tons)
Figure 37. Europe Human Plasma Derivative Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Human Plasma Derivative Sales 2018-2023 (Tons)
Figure 39. Middle East & Africa Human Plasma Derivative Revenue 2018-2023 ($ Millions)
Figure 40. Americas Human Plasma Derivative Sales Market Share by Country in 2022
Figure 41. Americas Human Plasma Derivative Revenue Market Share by Country in 2022
Figure 42. Americas Human Plasma Derivative Sales Market Share by Type (2018-2023)
Figure 43. Americas Human Plasma Derivative Sales Market Share by Application (2018-2023)
Figure 44. United States Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Human Plasma Derivative Sales Market Share by Region in 2022
Figure 49. APAC Human Plasma Derivative Revenue Market Share by Regions in 2022
Figure 50. APAC Human Plasma Derivative Sales Market Share by Type (2018-2023)
Figure 51. APAC Human Plasma Derivative Sales Market Share by Application (2018-2023)
Figure 52. China Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Human Plasma Derivative Sales Market Share by Country in 2022
Figure 60. Europe Human Plasma Derivative Revenue Market Share by Country in 2022
Figure 61. Europe Human Plasma Derivative Sales Market Share by Type (2018-2023)
Figure 62. Europe Human Plasma Derivative Sales Market Share by Application (2018-2023)
Figure 63. Germany Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Human Plasma Derivative Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Human Plasma Derivative Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Human Plasma Derivative Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Human Plasma Derivative Sales Market Share by Application (2018-2023)
Figure 72. Egypt Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Human Plasma Derivative Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Human Plasma Derivative in 2022
Figure 78. Manufacturing Process Analysis of Human Plasma Derivative
Figure 79. Industry Chain Structure of Human Plasma Derivative
Figure 80. Channels of Distribution
Figure 81. Global Human Plasma Derivative Sales Market Forecast by Region (2024-2029)
Figure 82. Global Human Plasma Derivative Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Human Plasma Derivative Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Human Plasma Derivative Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Human Plasma Derivative Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Human Plasma Derivative Revenue Market Share Forecast by Application (2024-2029)
